Home » Publications

Calciphylaxis publications

Research from our experts has been featured in many high impact publications. Some of the most cited publications include:

  1. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. New England Journal of Medicine 2018;378(18):1704-1714.
  2. Nigwekar SU, Kroshinsky D, Nazarian RM, et al. Calciphylaxis: risk factors, diagnosis, and treatment. American Journal of Kidney Diseases 2015;66(1):133-146.
  3. Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 2008;3(4):1139-43. DOI: 10.2215/CJN.00530108.
  4. Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clinical Journal of the American Society of Nephrology 2013;8(7):1162-1170.
  5. Nigwekar SU, Zhao S, Wenger J, et al. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. J Am Soc Nephrol 2016;27(11):3421-3429. DOI: 10.1681/ASN.2015091065.
  6. Dutta P, Chaudet KM, Nazarian RM, Kroshinsky D, Nigwekar SU. Correlation between clinical and pathological features of cutaneous calciphylaxis. PLoS One. 2019 Jun 13;14(6):e0218155. doi: 10.1371/journal.pone.0218155. PMID: 31194797; PMCID: PMC6564670.
  7. Olaniran KO, Percy SG, Zhao S, Blais C, Jackson V, Kamdar MM, Goverman J, Kroshinsky D, Temel JS, Nigwekar SU, Eneanya ND. Palliative Care Use and Patterns of End-of-Life Care in Hospitalized Patients With Calciphylaxis. J Pain Symptom Manage. 2019 Feb;57(2):e1-e3. doi: 10.1016/j.jpainsymman.2018.10.514. Epub 2018 Nov 3. PMID: 30399415; PMCID: PMC6476330.
  8. Bajaj R, Courbebaisse M, Kroshinsky D, Thadhani RI, Nigwekar SU. Calciphylaxis in Patients With Normal Renal Function: A Case Series and Systematic Review. Mayo Clin Proc. 2018 Sep;93(9):1202-1212. doi: 10.1016/j.mayocp.2018.06.001. Epub 2018 Jul 27. PMID: 30060958.
  9. Nigwekar SU, Nazarian RM. Cutaneous calcification in patients with kidney disease is not always calciphylaxis. Kidney Int. 2018 Aug;94(2):244-246. doi: 10.1016/j.kint.2018.04.019. PMID: 30031445.
  10. Nigwekar SU, Jiramongkolchai P, Wunderer F, Bloch E, Ichinose R, Nazarian RM, Thadhani RI, Malhotra R, Bloch DB. Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis. Am J Nephrol. 2017;46(5):429-438. doi: 10.1159/000484418. Epub 2017 Nov 9. PMID: 29130990; PMCID: PMC5763243.
  11. Nigwekar SU, Bloch DB, Nazarian RM, Vermeer C, Booth SL, Xu D, Thadhani RI, Malhotra R. Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. J Am Soc Nephrol. 2017 Jun;28(6):1717-1722. doi: 10.1681/ASN.2016060651. Epub 2017 Jan 3. PMID: 28049648; PMCID: PMC5461787.

 

Additional list of our publications can be found at- https://pubmed.ncbi.nlm.nih.gov/?term=%28%28%28%28Nigwekar%5BAuthor%5D%29+OR+%28Goverman%2C+Jeremy%5BAuthor%5D%29%29+OR+%28Nazarian%2C+Rosalynn%5BAuthor%5D%29%29+OR+%28Kroshinsky%2C+Daniela%5BAuthor%5D%29%29+AND+%28calciphylaxis%5BTitle%5D%29&sort=date

Donate to calciphylaxis research here